Navigation Links
Hillenbrand Reports 2.4% Decline in Earnings Per Share on 3.8% Lower Revenues in Third Quarter 2009

BATESVILLE, Ind., Aug. 12 /PRNewswire-FirstCall/ -- Hillenbrand, Inc. (NYSE: HI) -- Hillenbrand, Inc. reported net revenues of $158.7 million for the third quarter of 2009, which ended June 30, 2009, a $6.3 million (3.8 percent) decline from the same period in fiscal 2008. The company posted net income of $25.4 million, a $1.3 million (4.9 percent) decline. The difference in as-adjusted net income for the quarter was negligible, reflecting minimal spending for separation costs and antitrust litigation. Earnings per diluted share decreased by $0.01 (2.4 percent) over the prior year period, from $0.42 to $0.41.

"Burial demand is typically diminished in the third and fourth quarters as a result of the seasonal effect of death trends. This year has been a bit unusual as there was a minimal instance of influenza and pneumonia, resulting in fewer North American burials," said Kenneth A. Camp, president and chief executive officer of Hillenbrand, Inc. "Additionally, the severity of the recession and uncertainty around improvements in the economy appear to have caused some consumers to be more cost-conscious as they make funeral purchase decisions."

Decreases in the cost of diesel fuel and some raw materials were important factors in the company's gross margin improvement from 40.2 percent to 41.6 percent (140 basis points), compared to the third quarter of fiscal 2008. Operating expenses also improved from $28.4 million to $27.3 million (3.9 percent). Investment income of $1.9 million was down $2.5 million (56.8 percent), primarily because of a $1.2 million decrease in the fair value of the investment portfolios of the limited partnerships held by the company.

Cash flow from operations remained strong at $33.3 million in the third quarter. Excluding a voluntary contr (0.4) - ---- --- Net cash flows 14.1 21.1 Cash and cash equivalents: At beginning of period 14.7 11.9 ---- ---- At end of period $28.8 $33.0 ===== =====

Disclosure Regarding Forward-Looking Statements

Throughout this release, we make a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. As the words imply, forward-looking statements are statements about the future, as contrasted with historical information. Our forward-looking statements are based on assumptions that we believe are reasonable, but by their very nature they are subject to a wide range of risks.

Words that could indicate we're making forward-looking statements include the following:

     intend      believe     plan            expect     may         goal
     become      pursue      estimate        will       forecast    continue
     targeted    increase    higher/lower    improve    progress    potential

This isn't an exhaustive list, but is simply intended to give you an idea of how we try to identify "forward-looking statements." The absence of any of these words, however, does not mean that the statement is not "forward-looking."

Here's the key point: Forward-looking statements are not guarantees of future performance, and our actual results could differ materially from those set forth in any forward-looking statements. Any number of factors - many of which are beyond our control - could cause our performance to differ significantly from those described in the forward-looking statements. These factors include, but are not limited to: the company's ongoing antitrust litigation; the company's dependence on its relationships with several large national providers; continued fluctuations in mortality rates and increased cremations; ongoing involvement in claims, lawsuits and governmental proceedings related to operations; failure of the company's announced strategic initiatives to achieve expected growth, efficiencies or cost reductions; failure of the company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances; competition from nontraditional sources in the funeral services business; volatility of the company's investment portfolio; increased costs or unavailability of raw materials; labor disruptions; the ability to retain executive officers and other key personnel; and certain tax-related matters. For a more in-depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in item 1A of the company's Annual Report on Form 10-K for the year ended Sept. 30, 2008, filed Dec. 9, 2008. The company assumes no obligation to update or revise any forward-looking information.


About Hillenbrand, Inc.

Hillenbrand, Inc. ( is the holding company for Batesville Casket Company, a leader in the North American death care industry through the sale of funeral services products, including burial caskets, cremation caskets, containers and urns, selection room display fixturing, and other personalization and memorialization products. HI-INC-F

ibution of $7.8 million to the company's pension plans, cash flows were largely flat compared with the same period in 2008.

"This recession has affected every part of the American economy, and for the first time, it's also affected our industry," Camp said. "We don't know if the way consumers are currently making decisions will linger or, as part of an economic recovery, people will return fully to their long-standing family burial traditions.

"The entire Hillenbrand team is working diligently to increase productivity, respond directly to the aggressive price competition in our industry and create new ways to meet the needs of our customers and their client families," Camp said.

Outlook for Fiscal Year 2009

Because significant uncertainty about the economy remains, it is more difficult than usual to forecast future results with accuracy; however, the company anticipates annual results will be within previously announced guidance, although closer to the low end of the range. On July 29, the U.S. Fifth Circuit Court of Appeals denied the plaintiffs' request for reconsideration in previously reported antitrust litigation. Due to this and other previously reported favorable court rulings, the company anticipates 2009 expenses related to this litigation will be lower than estimated in our guidance.

    Hillenbrand, Inc.
    (amounts in millions, except per share data)

                                Fiscal year ending September 30
                                             FY 09 Range
                                 FY 08     Low      High
                                 -----     ---      ----

    Net revenues                  $678     $650      $670
    Income before taxes           $153     $152      $162
    Tax rate                      39.2%    36.4%     35.4%
    Net income                     $93      $97      $105
    Average diluted shares
     outstanding                    63       61        61
    Diluted net income per
     share                       $1.49    $1.57     $1.70

    Excluding certain
     non-operating costs
     (antitrust litigation
     and separation*)
       Net income                 $108     $101      $109
       Diluted net income per
        share                    $1.73    $1.65     $1.78

*Non-GAAP Financial Disclosures and Reconciliations for Third Quarter 2009

While Hillenbrand, Inc. reports financial results in accordance with U.S. GAAP, this press release includes non-GAAP measures. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Hillenbrand uses the non-GAAP measures to evaluate and manage its operations and provides the information to investors so they can see the results "through the eyes" of management. Hillenbrand further believes that providing this information better enables investors to understand the ongoing operating performance of the company. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

    Hillenbrand, Inc.
    (amounts in millions)

                Three Months Ended   Three Months Ended    Fiscal Year 2009
                  June 30, 2008        June 30, 2009       Guidance Midpoint
                ------------------   ------------------    -----------------
                Pre-  Income  Post-  Pre-  Income  Post-   Pre-  Income  Post-
                Tax   Taxes   Tax    Tax   Taxes   Tax     Tax   Taxes   Tax
                ------------------   ------------------    ------------------

    GAAP net
     income    $41.0  $14.3  $26.7  $40.3  $14.9  $25.4  $156.9  $56.3  $100.6

       gation    0.9    0.3    0.6    0.3    0.1    0.2     7.0    2.6     4.4
      Separation 0.1      -    0.1      -      -      -     0.2    0.1     0.1
                 ---    ---    ---    ---    ---    ---     ---    ---     ---

    Adjusted net
     income    $42.0  $14.6  $27.4  $40.6  $15.0  $25.6  $164.1  $59.0  $105.1
               =====  =====  =====  =====  =====  =====  ======  =====  ======

Additional assumptions and discussion will be provided during the company's conference call later today.

Conference Call and Webcast

The company will sponsor a conference call and webcast for the investing public at 8 a.m. ET Wednesday, Aug. 12, 2009. During the event, management will discuss the results for the third quarter of fiscal year 2009, which ended June 30, 2009. The webcast will be available at and will be archived on the company's Web site through Aug. 11, 2010, for those unable to listen to the live webcast.

Participants may listen to the conference call by dialing 1-877-719-9795 (1-719-325-4783 for international callers). A replay of the call will be available through midnight Wednesday, Aug. 26, 2009, at 1-888-203-1112 (1-719-457-0820 for international callers). Please use the confirmation code 6524514.

    Hillenbrand, Inc.
    Consolidated Statements of Income (Unaudited)
    (amounts in millions, except per share data)

                                  Three Months Ended       Nine Months Ended
                                       June 30,                 June 30,
                                      --------                  --------
                                 2009          2008         2009         2008
                                 ----          ----         ----         ----

      Net revenues             $158.7        $165.0       $496.0       $519.3
      Cost of goods sold         92.7          98.6        285.9        302.8
                                 ----          ----        -----        -----

        Gross profit             66.0          66.4        210.1        216.5
      Operating expenses
       (including separation
       costs)                    27.3          28.4         87.8         99.2
                                 ----          ----         ----         ----

        Operating profit         38.7          38.0        122.3        117.3
      Interest expense           (0.3)         (1.4)        (1.8)        (1.4)
      Investment income (loss)
       and other                  1.9           4.4          4.2          3.9
                                  ---           ---          ---          ---

        Income before income
         taxes                   40.3          41.0        124.7        119.8
      Income tax expense         14.9          14.3         45.0         45.8
                                 ----          ----         ----         ----

        Net income              $25.4         $26.7        $79.7        $74.0
                                =====         =====        =====        =====

      Income per common
       share-basic and diluted  $0.41         $0.42        $1.29        $1.18
      Dividends per common
       share*                  $0.185       $0.1825       $0.555      $0.1825

      Average common shares
       outstanding - basic and
       diluted                   61.7          62.5         61.8         62.5

     * Our first dividend as a stand-alone public company was paid June 30,

    Hillenbrand, Inc.
    Consolidated Balance Sheets (Unaudited)
    (amounts in millions)

                                                      June 30,  September 30,
                                                        2009         2008
                                                        ----         ----
     Current Assets
       Cash and cash equivalents                       $28.8        $14.7
       Trade accounts receivable, net                   84.6         88.4
       Inventories                                      43.7         48.6
       Deferred income taxes                            19.2         22.4
       Other current assets                             10.7          7.5
                                                        ----          ---

         Total current assets                          187.0        181.6
     Property, net                                      86.5         90.8
     Intangible assets, net                             17.2         19.7
     Auction rate securities and related Put right      49.6         51.1
     Note receivable from Forethought Financial
      Group, Inc.                                      139.5        130.4
     Investments                                        18.5         25.2
     Deferred income taxes                              20.9         19.7
     Other assets                                       21.4         26.8
                                                        ----         ----

         Total Assets                                 $540.6       $545.3
                                                      ======       ======

     Current Liabilities
       Revolving credit facility                       $80.0       $100.0
       Trade accounts payable                           12.8         15.8
       Accrued compensation                             23.7         24.6
       Accrued customer rebates                         17.2         20.4
       Other current liabilities                        15.8         20.8
       Due to Hill-Rom Holdings, Inc.                    0.1          4.4
                                                         ---          ---

         Total current liabilities                     149.6        186.0
     Deferred compensation, long-term portion            4.7          7.0
     Accrued pension and postretirement
      healthcare, long-term portion                     27.5         33.5
     Other long-term liabilities                        32.9         30.4
                                                        ----         ----

         Total Liabilities                             214.7        256.9
                                                       -----        -----

     Commitments and contingencies
     Common stock, no par value, 199.0 shares
      authorized; 62.8 and 62.4 shares issued,
      61.8 and 62.1 shares outstanding at June 30,
      2009 and September 30, 2008, respectively            -            -
     Additional paid-in-capital                        296.4        286.4
     Retained earnings                                  68.2         23.0
     Treasury stock, at cost; 1.0 and 0.3 shares
      at June 30, 2009 and September 30, 2008,
      respectively                                     (18.4)        (6.2)
     Accumulated other comprehensive loss              (20.3)       (14.8)
                                                       -----        -----

         Total Shareholders' Equity                    325.9        288.4
                                                       -----        -----

     Total Liabilities and Shareholders' Equity       $540.6       $545.3
                                                      ======       ======

    Hillenbrand, Inc.
    Consolidated Statements of Cash Flows (Unaudited)
    (amounts in millions)

                                                  Nine Months Ended June 30,
                                                    2009              2008
                                                    ----              ----
     Operating Activities:
     Net income                                    $79.7             $74.0
     Adjustments to reconcile net income to net
      cash flows from operating activities:
       Depreciation and amortization                13.8              14.1
       (Benefit) provision for deferred income
        taxes                                       (1.2)              1.0
       Net gain on disposal of property             (0.1)             (0.1)
       Interest income on note receivable from
        Forethought Financial Group, Inc.           (9.1)             (2.8)
       Equity in net (income) loss from
        affiliates                                   5.7              (0.4)
       Distribution of earnings from affiliates      0.4                 -
       Stock based compensation                      5.5               0.5
       Trade accounts receivable                     3.2               5.2
       Inventories                                   4.6              (2.9)
       Other current assets                          2.1              (3.8)
       Trade accounts payable                       (2.9)             (4.2)
       Accrued expenses and other current
        liabilities                                 (7.5)              4.1
       Income taxes prepaid or payable              (2.8)             17.5
       Amounts due to/from Hill-Rom Holdings,
        Inc.                                           -             (11.1)
       Defined benefit plan funding                 (9.0)             (1.3)
       Deferred compensation                        (2.5)             (0.5)
       Other, net                                    5.0               1.5
                                                     ---               ---

         Net cash provided by operating activities  84.9              90.8
                                                    ----              ----

     Investing Activities:
       Capital expenditures                         (7.1)             (6.1)
       Proceeds on disposal of property              0.2               0.3
       Payment for acquisition of business, net
        of cash acquired                               -              (0.4)
       Proceeds from sale or redemption of
        auction rate securities                      1.8               2.7
       Capital contributions to affiliates          (0.6)                -
       Return of investment capital from
        affiliates                                   2.1               0.6
                                                     ---               ---

         Net cash used in investing activities      (3.6)             (2.9)
                                                    ----              ----

     Financing Activities:
       Proceeds from revolving credit facility      40.0             250.0
       Repayments on revolving credit facility     (60.0)           (140.0)
       Deferred financing costs and other           (0.1)             (0.9)
       Payment of dividends on common stock        (34.2)            (11.4)
       Purchase of common stock                    (12.5)                -
       Net change in advances to former parent         -            (290.3)
       Cash received from parent in connection
        with separation                                -             125.4
       Proceeds on issuance of common stock            -               0.4
                                                     ---               ---

         Net cash used in financing activities     (66.8)            (66.8)
                                                   -----             -----

     Effect of exchange rate changes on cash
      and cash equivalents                      
SOURCE Hillenbrand, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hillenbrand Announces Third-Quarter Earnings Release Date and Conference Call
2. Hillenbrand Expects to Report Second-Quarter Net Revenue of $170.8 Million and Revises 2009 Guidance
3. Hillenbrand Board of Directors Appoints Joe Loughrey as New Director
4. Hillenbrand Announces Dividend of $0.185 Per Share
5. Hillenbrand, Inc. Announces Corrected First-Quarter Earnings Release and Conference Call Date
6. Hillenbrand, Inc. Announces First-Quarter Earnings Release Date and Conference Call
7. Hillenbrand, Inc. Appoints Jan Santerre Vice President of Lean Business
8. Hillenbrand, Inc. Increases Quarterly Dividend to $0.185 Per Share
9. Hillenbrand, Inc. Reports Fourth-Quarter Revenue of $159 Million and Earnings Per Share of $0.31
10. Hillenbrand, Inc. Announces Fourth-Quarter Earnings Release Date and Conference Call
11. Hillenbrand, Inc. Announces Analyst/Investor Conference in New York Dec. 3
Post Your Comments:
(Date:10/9/2015)... ... ... Head Over Heels Athletic Arts gymnast, Madelyn Williams, will attend the USA ... Huntsville, Texas on October 17-21. , "It's very exciting to be invited to ... director, said. “It's a stepping stone into the U.S. elite system where Maddie and ...
(Date:10/9/2015)... ... October 09, 2015 , ... The Asthma and Allergy ... Centers for Disease Control and Prevention (CDC) to improve the knowledge and skills of ... has been awarded a project by the CDC and allows AAFA to continue vital ...
(Date:10/9/2015)... ... 09, 2015 , ... "As a nurse, I care for male patients who ... to wear large diapers or pads. We came up with this as a better ... urine leaking from the tip of the penis. This prevents stains from forming on ...
(Date:10/9/2015)... ... October 09, 2015 , ... ViewPoint Center, a teen ... many teenagers facing mental illness, the stigma associated with mental illness causes many to ... Center understands the importance of supporting teens with mental illness , providing teens ...
(Date:10/9/2015)... ... October 09, 2015 , ... Deadly, record-smashing rainfall ... Community Foundation (CCCF) in Columbia, South Carolina. In response, the Foundation has established ... victims – both short and long term. 100% of monies donated will go ...
Breaking Medicine News(10 mins):
... Government plans to hasten patient treatment has included bestowing ... drugs//. ,Under this plan, nurses and pharmacists ... for common illnesses that range from acne to tonsillitis. ... clinics and will soon be able to prescribe drugs ...
... industry a panel comprising European experts recommended Sanofi-Aventis's anti-obesity pill ... news was brought to light by the company itself. ... block a pleasure centre and so fight obesity. People on ... with eating. ,Data from a trial involving more ...
... College of Nursing congress last week shouted at Patricia Hewitt ... their hostility to a government which was a great ally ... and what are they furious about? There are 70,000 nurses ... has also risen considerably over the past three years. Les ...
... in the May issue of the journal Medical Care say ... alright to discuss religion with their patients.// However, only three ... beliefs and only half of them bother to query a ... ten physicians routinely mentions his or her religious beliefs and ...
... the rain, there seems to be enough shine, making Washington, ... to the Environmental// Protection Agency. , ,The ... to schools that comprise of 40 activity cards and a ... the sun's UV rays. , ,Demonstrators apply ...
... occur in children whose mothers report difficulties with substance ... delivery, reports a study published in the Archives of ... / mood disorders, smoking, maternal drinking, substance or drug ... that can contribute to behavior problems in children. Although ...
Cached Medicine News:
(Date:10/9/2015)... CINCINNATI , Oct. 9, 2015  Xavier ... Thinking labs with Konica Minolta Medical Imaging (KMMI) on ... utilize Design Thinking to help healthcare providers imagine and ... a visual roadmap that they can customize for their ... Primary Imaging is the initial procedure, or study, in ...
(Date:10/9/2015)... 2015 ® ) ... Kolonoskopie im Rahmen eines Screenings, einer beobachtenden ... bewertete auch die Compliance, Sicherheit, Patientenakzeptanz und ... ) an erwachsenen Patienten vergleicht, die sich ... beobachtenden oder einer diagnostischen Kolonoskopie unterziehen. Die ...
(Date:10/9/2015)... BETHESDA, Maryland , October 9, 2015 ... Pharmaceuticals Inc. (OTCQB: CNBX) has announced its execution of ... Debt & Liabilities Agreement with Cannabics, Inc. a Delaware Corporation, ... the company. --> --> ... internal restructuring of the Company, whereby the Research and ...
Breaking Medicine Technology:
... 2011 Hospira, Inc. (NYSE: HSP ), a ... that the company will present at the Sanford C. Bernstein ... in New York. The presentation is scheduled to ... 2011.  It will be available to all interested parties through ...
... May 12, 2011 Men and women infected with ... their sexual partners through initiation of oral antiretroviral therapy ... study conducted by the HIV Prevention Trials Network (HPTN), ... HIV through cutting-edge biomedical, behavioral, and structural interventions. ...
Cached Medicine Technology:
Gently curved shaft with blunt angled tip is ideal for chopping the lens during anterior chamber phacoemulsification....
5 mm curved hook with markings at 14 mm and 20 mm from tip. Flat serrated handle with polished finish. Overall length: 4.7 inches....
#2 10 mm hook. Flat serrated handle with polished finish. Overall length: 5.5 inches....
2.0 mm bulbous tip with 6 mm flat portion. Flat serrated handle with polished finish. Overall length: 5.4 inches. Most popular size or model....
Medicine Products: